-
Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma. Front Immunol. 2025; 16:1568962. Chen PJ, Devkota S, Shiao S, Hendifar A, Yang JD. PMID: 41438742; PMCID: PMC12719415.
-
Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review. Life (Basel). 2025 Oct 20; 15(10). Chen L, Shiao SL, Yuan Y. PMID: 41157306; PMCID: PMC12565630.
-
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages. Nat Cancer. 2025 Oct; 6(10):1754. Petroni G, Galassi C, Gouin KH, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L. PMID: 40702362.
-
Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI. Radiol Artif Intell. 2025 09; 7(5):e240769. Wu C, Wang L, Wang N, Shiao S, Dou T, Hsu YC, Christodoulou AG, Xie Y, Li D. PMID: 40631989; PMCID: PMC12464716.
-
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages. Nat Cancer. 2025 Oct; 6(10):1656-1675. Petroni G, Galassi C, Gouin KH, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L. PMID: 40624238.
-
Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapy. Cardiooncology. 2025 Jul 03; 11(1):62. Nesseler JP, Silos KD, Peony O, Singh A, Belen P, Kamrava MR, Jang JK, Shiao SL, Kwan AC, Ramin C, Mak RH, Nikolova AP, Atkins KM. PMID: 40611344; PMCID: PMC12225161.
-
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures. iScience. 2025 Jul 18; 28(7):112808. Mebane RH, Noel T, Ing N, Gouin KH, Shah A, Zitser D, Martinez A, Gupta G, Demaria S, Galluzzi L, Ho A, McArthur H, Shiao SL, Knott SRV. PMID: 40599321; PMCID: PMC12209978.
-
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. J Clin Oncol. 2024 Dec 20; 42(36):4282-4293. Ho AY, Shiao S, Kobald SA, Chen J, Duda DG, Ly A, Bossuyt V, Cho HL, Arnold B, Knott S, Gupta GP, McAndrew P, Karlan S, Tighiouart M, Muzikansky A, Basho R, McArthur H. PMID: 39298718; PMCID: PMC12422141.
-
Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024 01 08; 42(1):70-84.e8. Shiao SL, Gouin KH, Ing N, Ho A, Basho R, Shah A, Mebane RH, Zitser D, Martinez A, Mevises NY, Ben-Cheikh B, Henson R, Mita M, McAndrew P, Karlan S, Giuliano A, Chung A, Amersi F, Dang C, Richardson H, Shon W, Dadmanesh F, Burnison M, Mirhadi A, Zumsteg ZS, Choi R, Davis M, Lee J, Rollins D, Martin C, Khameneh NH, McArthur H, Knott SRV. PMID: 38194915.
-
Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis. J Hepatol. 2024 03; 80(3):443-453. Fan W, Cao D, Yang B, Wang J, Li X, Kitka D, Li TWH, You S, Shiao S, Gangi A, Posadas E, Di Vizio D, Tomasi ML, Seki E, Mato JM, Yang H, Lu SC. PMID: 38086446; PMCID: PMC10922446.
-
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial. Nat Commun. 2023 09 02; 14(1):5332. Monjazeb AM, Daly ME, Luxardi G, Maverakis E, Merleev AA, Marusina AI, Borowsky A, Mirhadi A, Shiao SL, Beckett L, Chen S, Eastham D, Li T, Vick LV, McGee HM, Lara F, Garcia L, Morris LA, Canter RJ, Riess JW, Schalper KA, Murphy WJ, Kelly K. PMID: 37658083; PMCID: PMC10474145.
-
Association of x-ray velocimetry (XV) ventilation analysis compared to spirometry. Front Med Technol. 2023; 5:1148310. Kirkness JP, Dusting J, Eikelis N, Pirakalathanan P, DeMarco J, Shiao SL, Fouras A. PMID: 37440838; PMCID: PMC10335741.
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference. Oncoimmunology. 2023; 12(1):2222560. Gregucci F, Spada S, Barcellos-Hoff MH, Bhardwaj N, Chan Wah Hak C, Fiorentino A, Guha C, Guzman ML, Harrington K, Herrera FG, Honeychurch J, Hong T, Iturri L, Jaffee E, Karam SD, Knott SRV, Koumenis C, Lyden D, Marciscano AE, Melcher A, Mondini M, Mondino A, Morris ZS, Pitroda S, Quezada SA, Santambrogio L, Shiao S, Stagg J, Telarovic I, Timmerman R, Vozenin MC, Weichselbaum R, Welsh J, Wilkins A, Xu C, Zappasodi R, Zou W, Bobard A, Demaria S, Galluzzi L, Deutsch E, Formenti SC. PMID: 37363104; PMCID: PMC10286673.
-
Chronic antigen in solid tumors drives a distinct program of T cell residence. Sci Immunol. 2023 06 08; 8(84):eadd5976. Gavil NV, Scott MC, Weyu E, Smith OC, O'Flanagan SD, Wijeyesinghe S, Lotfi-Emran S, Shiao SL, Vezys V, Masopust D. PMID: 37267383; PMCID: PMC10569081.
-
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. JAMA Oncol. 2023 06 01; 9(6):800-807. Ryu S, Deshmukh S, Timmerman RD, Movsas B, Gerszten P, Yin FF, Dicker A, Abraham CD, Zhong J, Shiao SL, Tuli R, Desai A, Mell LK, Iyengar P, Hitchcock YJ, Allen AM, Burton S, Brown D, Sharp HJ, Dunlap NE, Siddiqui MS, Chen TH, Pugh SL, Kachnic LA. PMID: 37079324; PMCID: PMC10119775.
-
A Single-Institution Retrospective Study of Three-Fraction HDR Accelerated Partial Breast Irradiation. Brachytherapy. 2023 May-Jun; 22(3):361-367. Chung EM, Nguyen AT, Mirhadi A, Steers JM, Phillips T, Atkins KM, Burnison M, Shiao SL, Kamrava M. PMID: 36997449.
-
Activated T cell therapy targeting glioblastoma cancer stem cells. Sci Rep. 2023 01 05; 13(1):196. Miyaguchi K, Wang H, Black KL, Shiao SL, Wang R, Yu JS. PMID: 36604465; PMCID: PMC9814949.
-
miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC. Cancers (Basel). 2022 Oct 27; 14(21). Shibata T, Cao DY, Dar TB, Ahmed F, Bhat SA, Veiras LC, Bernstein EA, Khan AA, Chaum M, Shiao SL, Tourtellotte WG, Giani JF, Bernstein KE, Cui X, Vail E, Khan Z. PMID: 36358691; PMCID: PMC9655574.
-
Quantitative Nodal Burden and Mortality Across Solid Cancers. J Natl Cancer Inst. 2022 07 11; 114(7):1003-1011. Nguyen AT, Luu M, Nguyen VP, Lu DJ, Shiao SL, Kamrava M, Atkins KM, Mita AC, Scher KS, Spratt DE, Faries MB, Daskivich TJ, Lin DC, Chen MM, Clair JM, Sandler HM, Ho AS, Zumsteg ZS. PMID: 35311991; PMCID: PMC9275768.
-
Single-cell RNA-seq of a soft-tissue sarcoma model reveals the critical role of tumor-expressed MIF in shaping macrophage heterogeneity. Cell Rep. 2022 06 21; 39(12):110977. Tessaro FHG, Ko EY, De Simone M, Piras R, Broz MT, Goodridge HS, Balzer B, Shiao SL, Guarnerio J. PMID: 35732118; PMCID: PMC9249098.
-
Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo. Cancer Lett. 2022 05 28; 534:215613. Yue P, Zhu Y, Brotherton-Pleiss C, Fu W, Verma N, Chen J, Nakamura K, Chen W, Chen Y, Alonso-Valenteen F, Mikhael S, Medina-Kauwe L, Kershaw KM, Celeridad M, Pan S, Limpert AS, Sheffler DJ, Cosford NDP, Shiao SL, Tius MA, Lopez-Tapia F, Turkson J. PMID: 35276290; PMCID: PMC9867837.
-
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma. Clin Cancer Res. 2022 02 15; 28(4):689-696. Hu JL, Omofoye OA, Rudnick JD, Kim S, Tighiouart M, Phuphanich S, Wang H, Mazer M, Ganaway T, Chu RM, Patil CG, Black KL, Shiao SL, Wang R, Yu JS. PMID: 34862245.
-
Comparative Proteomic Analysis of HPV(+) Oropharyngeal Squamous Cell Carcinoma Recurrence. J Proteome Res. 2022 01 07; 21(1):200-208. Ho AS, Robinson A, Shon W, Laury A, Raedschelders K, Venkatraman V, Holewinski R, Zhang Y, Shiao SL, Chen MM, Mallen-St Clair J, Lin DC, Zumsteg ZS, Van Eyk JE. PMID: 34846153.
-
HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer. Endocrinology. 2021 10 01; 162(10). Mazumder A, Shiao S, Haricharan S. PMID: 34320193; PMCID: PMC8379900.
-
Why do we need better omics in the breast cancer care? EBioMedicine. 2021 Oct; 72:103598. Gertych A, Shiao SL. PMID: 34563921; PMCID: PMC8477140.
-
Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell. 2021 09 13; 39(9):1202-1213.e6. Shiao SL, Kershaw KM, Limon JJ, You S, Yoon J, Ko EY, Guarnerio J, Potdar AA, McGovern DPB, Bose S, Dar TB, Noe P, Lee J, Kubota Y, Maymi VI, Davis MJ, Henson RM, Choi RY, Yang W, Tang J, Gargus M, Prince AD, Zumsteg ZS, Underhill DM. PMID: 34329585; PMCID: PMC8830498.
-
A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth. Mol Ther. 2022 02 02; 30(2):672-687. Han B, Alonso-Valenteen F, Wang Z, Deng N, Lee TY, Gao B, Zhang Y, Xu Y, Zhang X, Billet S, Fan X, Shiao S, Bhowmick N, Medina-Kauwe L, Giuliano A, Cui X. PMID: 34274535; PMCID: PMC8821896.
-
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? J Immunother Cancer. 2021 04; 9(4). Demaria S, Guha C, Schoenfeld J, Morris Z, Monjazeb A, Sikora A, Crittenden M, Shiao S, Khleif S, Gupta S, Formenti SC, Vikram B, Coleman CN, Ahmed MM. PMID: 33827904; PMCID: PMC8031689.
-
Advances in Combining Radiation and Immunotherapy in Breast Cancer. Clin Breast Cancer. 2021 04; 21(2):143-152. Nguyen AT, Shiao SL, McArthur HL. PMID: 33810972; PMCID: PMC8562891.
-
Five-dimensional quantitative low-dose Multitasking dynamic contrast- enhanced MRI: Preliminary study on breast cancer. Magn Reson Med. 2021 06; 85(6):3096-3111. Wang N, Xie Y, Fan Z, Ma S, Saouaf R, Guo Y, Shiao SL, Christodoulou AG, Li D. PMID: 33427334.
-
Variations in the association of grade with survival across the head and neck cancer landscape. Head Neck. 2021 04; 43(4):1105-1115. Anderson EM, Luu M, Balzer BL, Scher KS, Mita AC, Lu DJ, Shiao SL, Clair JM, Ho AS, Zumsteg ZS. PMID: 33300641.
-
Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma. JAMA Oncol. 2020 10 01; 6(10):1555-1562. Nguyen AT, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, Shiao SL, Ho AS, Zumsteg ZS. PMID: 32816023; PMCID: PMC7441465.
-
The role of concomitant chemoradiotherapy in AJCC 7th edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus era. Oral Oncol. 2020 11; 110:104882. Lu DJ, Luu M, Nguyen AT, Shiao SL, Scher K, Mita A, Anderson E, Clair JM, Ho AS, Zumsteg ZS. PMID: 32650257.
-
Improved survival in women versus men with merkel cell carcinoma. J Am Acad Dermatol. 2021 Feb; 84(2):321-329. Tam M, Luu M, Barker CA, Gharavi NM, Hamid O, Shiao SL, Nguyen AT, Lu DJ, Ho AS, Zumsteg ZS. PMID: 32423829.
-
The association between facility volume and overall survival in patients with Merkel cell carcinoma. J Surg Oncol. 2020 Aug; 122(2):254-262. Yoshida EJ, Luu M, Freeman M, Essner R, Gharavi NM, Shiao SL, Mallen-St Clair J, Hamid O, Ho AS, Zumsteg ZS. PMID: 32297324.
-
Effects of Radiation on the Tumor Microenvironment. Semin Radiat Oncol. 2020 04; 30(2):145-157. Monjazeb AM, Schalper KA, Villarroel-Espindola F, Nguyen A, Shiao SL, Young K. PMID: 32381294; PMCID: PMC8764968.
-
Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy. Clin Otolaryngol. 2020 01; 45(1):63-72. Sittig MP, Luu M, Yoshida EJ, Scher K, Mita A, Shiao SL, Lu DJ, Mallen-St Clair J, Ho AS, Zumsteg ZS. PMID: 31661188.
-
Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. Oral Oncol. 2019 12; 99:104472. Lu DJ, Luu M, Nguyen AT, Scher KS, Clair JM, Mita A, Shiao SL, Ho AS, Zumsteg ZS. PMID: 31704556.
-
Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature. J Immunother. 2019 Nov/Dec; 42(9):354-358. Huang J, Shiao SL, Furuya H, Rosser CJ. PMID: 31107371; PMCID: PMC6783344.
-
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation. Ann Oncol. 2019 10 01; 30(10):1669. Zumsteg ZS, Luu M, Kim S, Tighiouart M, Mita A, Scher KS, Lu DJ, Shiao SL, Mallen-St Clair J, Ho AS. PMID: 31168574; PMCID: PMC6857612.
-
Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments? Cancer. 2020 01 01; 126(1):58-66. Yoshida EJ, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, Nguyen AT, Shiao SL, Ho AS, Zumsteg ZS. PMID: 31536144.
-
Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy. Cancer Epidemiol. 2019 10; 62:101578. Vidal AC, Howard LE, Wiggins E, De Hoedt AM, Shiao SL, Knott S, Taioli E, Fowke JH, Freedland SJ. PMID: 31377571; PMCID: PMC8764953.
-
Survival Impact of Adjuvant Therapy in Salivary Gland Cancers following Resection and Neck Dissection. Otolaryngol Head Neck Surg. 2019 06; 160(6):1048-1057. Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Yoshida EJ, Mallen-St Clair J, Shiao SL, Leivo I, Zumsteg ZS. PMID: 30721113.
-
Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy. Front Immunol. 2018; 9:3077. Dar TB, Henson RM, Shiao SL. PMID: 30692991; PMCID: PMC6339921.
-
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer. EBioMedicine. 2019 Feb; 40:375-381. Tuli R, Shiao SL, Nissen N, Tighiouart M, Kim S, Osipov A, Bryant M, Ristow L, Placencio-Hickok V, Hoffman D, Rokhsar S, Scher K, Klempner SJ, Noe P, Davis MJ, Wachsman A, Lo S, Jamil L, Sandler H, Piantadosi S, Hendifar A. PMID: 30635165; PMCID: PMC6412162.
-
Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation. Ann Oncol. 2019 01 01; 30(1):76-84. Zumsteg ZS, Luu M, Kim S, Tighiouart M, Mita A, Scher KS, Lu DJ, Shiao SL, Mallen-St Clair J, Ho AS. PMID: 30395159; PMCID: PMC6336000.
-
Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining. Front Immunol. 2018; 9:2925. Saylor J, Ma Z, Goodridge HS, Huang F, Cress AE, Pandol SJ, Shiao SL, Vidal AC, Wu L, Nickols NG, Gertych A, Knudsen BS. PMID: 30619287; PMCID: PMC6302234.
-
Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications. Eur J Cancer. 2018 11; 103:195-204. Lu DJ, Luu M, Mita A, Scher K, Shiao SL, Yoshida EP, Sittig MP, Mallen-St Clair J, Ho AS, Zumsteg ZS. PMID: 30268920.
-
Prometastatic Molecular Profiles in Breast Tumors From Socially Isolated Women. JNCI Cancer Spectr. 2018 Jul; 2(3):pky029. Bower JE, Shiao SL, Sullivan P, Lamkin DM, Atienza R, Mercado F, Arevalo J, Asher A, Ganz PA, Cole SW. PMID: 30057973; PMCID: PMC6054021.
-
Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer. JAMA Oncol. 2018 07 01; 4(7):985-989. Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS. PMID: 29192305; PMCID: PMC6584272.
-
Development of a novel salivary gland cancer lymph node staging system. Cancer. 2018 08 01; 124(15):3171-3180. Aro K, Ho AS, Luu M, Kim S, Tighiouart M, Clair JM, Yoshida EJ, Shiao SL, Leivo I, Zumsteg ZS. PMID: 29742277; PMCID: PMC6097925.
-
Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification. Head Neck. 2018 06; 40(6):1228-1236. Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Ho AS, Zumsteg ZS. PMID: 29417700.
-
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. J Immunother Cancer. 2018 01 29; 6(1):6. Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. PMID: 29375032; PMCID: PMC5787916.
-
The role of macrophage phenotype in regulating the response to radiation therapy. Transl Res. 2018 01; 191:64-80. Shi X, Shiao SL. PMID: 29175267; PMCID: PMC6018060.
-
Facility Volume and Survival in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):408-417. Yoshida EJ, Luu M, David JM, Kim S, Mita A, Scher K, Shiao SL, Tighiouart M, Lee NY, Ho AS, Zumsteg ZS. PMID: 29100787.
-
Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate. Diagn Pathol. 2017 Sep 18; 12(1):69. Ma Z, Shiao SL, Yoshida EJ, Swartwood S, Huang F, Doche ME, Chung AP, Knudsen BS, Gertych A. PMID: 28923066; PMCID: PMC5604347.
-
Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer. J Clin Oncol. 2017 Nov 01; 35(31):3601-3609. Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Van Eyk JE, Zumsteg ZS. PMID: 28880746; PMCID: PMC5791830.
-
Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base. Cancer. 2017 Dec 01; 123(23):4583-4593. Zumsteg ZS, Luu M, Yoshida EJ, Kim S, Tighiouart M, David JM, Shiao SL, Mita AC, Scher KS, Sherman EJ, Lee NY, Ho AS. PMID: 28817183; PMCID: PMC5745815.
-
Predictors of survival in head and neck mucosal melanoma. Oral Oncol. 2017 10; 73:36-42. Schmidt MQ, David J, Yoshida EJ, Scher K, Mita A, Shiao SL, Ho AS, Zumsteg ZS. PMID: 28939074.
-
Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer. 2017 Oct 15; 123(20):3933-3942. David JM, Ho AS, Luu M, Yoshida EJ, Kim S, Mita AC, Scher KS, Shiao SL, Tighiouart M, Zumsteg ZS. PMID: 28640546.
-
Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer. Cancer. 2017 05 01; 123(9):1555-1565. Zumsteg ZS, Kim S, David JM, Yoshida EJ, Tighiouart M, Shiao SL, Scher K, Mita A, Sherman EJ, Lee NY, Ho AS. PMID: 28001302.
-
The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era. Cancer. 2017 04 15; 123(8):1345-1353. Zumsteg ZS, Lok BH, Ho AS, Drill E, Zhang Z, Riaz N, Shiao SL, Ma J, McBride SM, Tsai CJ, Baxi SS, Sherman EJ, Lee NY. PMID: 27984656; PMCID: PMC5384883.
-
Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States. JAMA Oncol. 2016 Dec 01; 2(12):1617-1623. Zumsteg ZS, Cook-Wiens G, Yoshida E, Shiao SL, Lee NY, Mita A, Jeon C, Goodman MT, Ho AS. PMID: 27415639.
-
Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res. 2016 Sep 01; 22(17):4328-40. Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ. PMID: 26979392; PMCID: PMC5010514.
-
Regulation of prostate cancer progression by the tumor microenvironment. Cancer Lett. 2016 09 28; 380(1):340-8. Shiao SL, Chu GC, Chung LW. PMID: 26828013; PMCID: PMC5317350.
-
Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology. Curr Treat Options Cardiovasc Med. 2015 Dec; 17(12):60. Xie Y, Collins WJ, Audeh MW, Shiao SL, Gottlieb RA, Goodman MT, Merz CN, Mehta PK. PMID: 26490280; PMCID: PMC6364685.
-
Dosimetric Comparison Between 3-Dimensional Conformal and Robotic SBRT Treatment Plans for Accelerated Partial Breast Radiotherapy. Technol Cancer Res Treat. 2016 06; 15(3):437-45. Goggin LM, Descovich M, McGuinness C, Shiao S, Pouliot J, Park C. PMID: 26335703.
-
Nuclear glutaredoxin 3 is critical for protection against oxidative stress-induced cell death. Free Radic Biol Med. 2015 Aug; 85:197-206. Pham K, Pal R, Qu Y, Liu X, Yu H, Shiao SL, Wang X, O'Brian Smith E, Cui X, Rodney GG, Cheng N. PMID: 25975981; PMCID: PMC4902114.
-
Impact of the immune system and immunotherapy in colorectal cancer. J Gastrointest Oncol. 2015 Apr; 6(2):208-23. Markman JL, Shiao SL. PMID: 25830040; PMCID: PMC4311093.
-
Clinical experience using a video-guided spirometry system for deep inhalation breath-hold radiotherapy of left-sided breast cancer. J Appl Clin Med Phys. 2015 Mar 08; 16(2):5218. Yang W, McKenzie EM, Burnison M, Shiao S, Mirhadi A, Hakimian B, Reznik R, Tuli R, Sandler H, Fraass BA. PMID: 26103193; PMCID: PMC5690070.
-
TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy. Cancer Immunol Res. 2015 May; 3(5):518-25. Shiao SL, Ruffell B, DeNardo DG, Faddegon BA, Park CC, Coussens LM. PMID: 25716473; PMCID: PMC4420686.
-
Immune microenvironments in solid tumors: new targets for therapy. Genes Dev. 2011 Dec 15; 25(24):2559-72. Shiao SL, Ganesan AP, Rugo HS, Coussens LM. PMID: 22190457; PMCID: PMC3248678.
-
Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy. Phys Med Biol. 2011 Dec 21; 56(24):7767-75. Shiao SL, Sahgal A, Hu W, Jabbari S, Chuang C, Descovich M, Hsu IC, Gottschalk AR, Roach M, Ma L. PMID: 22107791.
-
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011 Jun; 1(1):54-67. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirström K, West BL, Coussens LM. PMID: 22039576; PMCID: PMC3203524.
-
Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):228-34. Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M, Gottschalk AR. PMID: 21183287.
-
The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia. 2010 Dec; 15(4):411-21. Shiao SL, Coussens LM. PMID: 21161342; PMCID: PMC3011087.
-
Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol. 2007 Oct 01; 179(7):4397-404. Shiao SL, Kirkiles-Smith NC, Shepherd BR, McNiff JM, Carr EJ, Pober JS. PMID: 17878335.
-
TCR signaling antagonizes rapid IP-10-mediated transendothelial migration of effector memory CD4+ T cells. J Immunol. 2007 Mar 01; 178(5):3237-43. Manes TD, Shiao SL, Dengler TJ, Pober JS. PMID: 17312172.
-
Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities. Transplantation. 2007 Feb 15; 83(3):304-13. Shiao SL, McNiff JM, Masunaga T, Tamura K, Kubo K, Pober JS. PMID: 17297405.
-
A dosimetric evaluation of conventional helmet field irradiation versus two-field intensity-modulated radiotherapy technique. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):621-31. Yu JB, Shiao SL, Knisely JP. PMID: 17276616.
-
Memory T cells and their costimulators in human allograft injury. J Immunol. 2005 Oct 15; 175(8):4886-96. Shiao SL, McNiff JM, Pober JS. PMID: 16210590.
-
T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest. 2004 Sep; 114(6):846-56. Koh KP, Wang Y, Yi T, Shiao SL, Lorber MI, Sessa WC, Tellides G, Pober JS. PMID: 15372109; PMCID: PMC516264.
-
T lymphocyte-endothelial cell interactions. Annu Rev Immunol. 2004; 22:683-709. Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. PMID: 15032593.
-
Cutting Edge: Internalization of transduced E-selectin by cultured human endothelial cells: comparison of dermal microvascular and umbilical vein cells and identification of a phosphoserine-type di-leucine motif. J Immunol. 2002 Mar 01; 168(5):2091-5. Kluger MS, Shiao SL, Bothwell AL, Pober JS. PMID: 11859093.
-
Biotechnology at Yale. Yale J Biol Med. 2001 May-Jun; 74(3):197-9. Shiao S. PMID: 11501716; PMCID: PMC2588710.
US